FIXX - Homology Medicines, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
1,984
1,666
3,684
0
0
Operating Expense
123,296
111,609
65,248
29,657
10,000
Operating Income
-121,312
-109,943
-61,564
-29,657
-10,000
Net Non Operating Interest Income Expense
5,917
6,027
4,349
542.635
24.201
Other Income Expense
-
-
-
-876
1,929
Pretax Income
-115,395
-103,916
-57,215
-29,991
-8,047
Net Income Common Stockholders
-115,395
-103,916
-57,215
-29,991
-8,047
Diluted NI Available to Com Stockholders
-115,395
-103,916
-57,215
-29,991
-8,047
Basic EPS
-
-
-0.002
-0.0016
0
Diluted EPS
-
-
-0.002
-0.0016
0
Basic Average Shares
-
-
28,552
18,602
18,602
Diluted Average Shares
-
-
28,552
18,602
18,602
Total Operating Income as Reported
-121,312
-109,943
-61,564
-29,657
-10,000
Total Expenses
123,296
111,609
65,248
29,657
10,000
Net Income from Continuing & Discontinued Operation
-115,395
-103,916
-57,215
-29,991
-8,047
Normalized Income
-115,395
-103,916
-57,215
-29,991
-8,047
Interest Income
5,917
6,027
4,349
542.635
24.201
Net Interest Income
5,917
6,027
4,349
542.635
24.201
EBIT
-121,312
-109,943
-61,564
-29,657
-10,000
EBITDA
-114,132
-
-
-
-
Reconciled Depreciation
7,180
6,318
1,289
684.214
239.797
Net Income from Continuing Operation Net Minority Interest
-115,395
-103,916
-57,215
-29,991
-8,047
Normalized EBITDA
-114,132
-103,625
-60,275
-28,973
-9,760
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0